Trulieve Cannabis Corp.
TRLV · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic
Close Sep 16, 2026 · end-of-day
Market Stats
Price History
Open in new tabAbout
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
Company Details
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Kimberly Rivers J.D.
- Employees
- 5.00K
- Headquarters
- 3494 Martin Hurst Road, Tallahassee, FL, United States, 32312, USA
- Website
- https://www.trulieve.com
Leadership
- Ms. Kimberly Rivers J.D.Founder, Chairman & CEO · b. 1978
- Mr. Jan ReeseChief Financial Officer · b. 1968
- Mr. Eric Raymond Powers III, J.D.Chief Legal Officer & Corporate Secretary · b. 1969
- Mr. Kyle LandrumChief Production Officer · b. 1986
- Mr. Brett WalshChief Accounting Officer · b. 1987
- Mr. Nilyum JhalaChief Technology Officer · b. 1977
- Phil BuckCorporate Communications Manager
- Mr. Timothy MoreyChief Sales Officer · b. 1963
- Mr. Elias AguileraChief Marketing Officer
- Mr. Michiel de ZwaanChief Human Resources Officer · b. 1971
Financials
Income Statement
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1.18B | $1.19B | $1.13B | $1.22B |
| Cost of Revenue | $470.01M | $470.75M | $540.57M | $529.10M |
| Gross Profit | $711.17M | $715.75M | $588.63M | $689.13M |
| Operating Income | $148.32M | $92.49M | $92.64M | $125.71M |
| EBITDA | $328.33M | $271.28M | $-32.31M | $239.75M |
| Net Income | $-116.38M | $-155.10M | $-526.80M | $-246.06M |
| Interest Expense | $63.45M | $62.19M | $81.57M | $73.42M |
Balance Sheet
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $2.70B | $2.87B | $2.73B | $3.40B |
| Total Liabilities | $1.55B | $1.62B | $1.32B | $1.47B |
| Total Equity | $1.16B | $1.26B | $1.41B | $1.93B |
| Cash | $255.53M | $238.80M | $201.37M | $207.19M |
| Total Debt | $563.62M | - | - | - |
| Net Debt | $308.09M | $241.38M | $281.46M | $441.18M |
Cash Flow
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $272.82M | $271.48M | $201.84M | $23.10M |
| Investing Cash Flow | $13.50M | - | - | - |
| Financing Cash Flow | $-270.50M | $-33.44M | $-175.59M | $177.80M |
| Capital Expenditure | $60.51M | $147.66M | $50.85M | $193.80M |
| Free Cash Flow | $212.31M | $123.82M | $150.99M | $-170.70M |
| Dividends Paid | - | - | $50.00K | $50.00K |
Earnings
| Report Date | Nov 6, 2026 | Aug 7, 2026 | May 7, 2026 | Feb 26, 2026 | Nov 5, 2025 | Aug 6, 2025 | May 7, 2025 | Feb 27, 2025 | Nov 5, 2024 | Aug 6, 2024 | May 9, 2024 | Feb 29, 2024 | Nov 9, 2023 | Aug 9, 2023 | May 10, 2023 | Mar 8, 2023 | Nov 9, 2022 | Aug 10, 2022 | May 12, 2022 | Mar 30, 2022 | Nov 15, 2021 | Aug 12, 2021 | May 13, 2021 | Mar 23, 2021 | Nov 17, 2020 | Aug 12, 2020 | May 20, 2020 | Nov 18, 2019 | Aug 14, 2019 | May 28, 2019 | Nov 19, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Estimate | $0.09 | $0.03 | $-0.05 | $-0.03 | $-0.07 | $-0.05 | $-0.09 | - | $-0.13 | - | $-0.11 | - | $-0.15 | $-0.18 | $-0.16 | - | $-0.03 | $0.08 | $0.06 | - | $0.28 | $0.30 | $0.31 | - | $0.21 | $0.12 | $0.11 | $0.13 | $0.12 | $0.11 | $0.14 |
| EPS Actual | - | $0.11 | $0.10 | $-0.02 | $-0.07 | $-0.04 | $-0.02 | $-0.31 | $-0.06 | $-0.07 | $-0.05 | $-0.18 | $-0.08 | $-0.08 | $-0.11 | $-0.41 | $0.02 | $-0.01 | $0.01 | $-0.40 | $0.17 | $0.33 | $0.27 | $0.02 | $0.04 | $0.06 | $0.12 | $0.55 | $0.52 | $0.13 | $0.18 |
| Surprise | - | 266.67% | 300.00% | 31.03% | 0.00% | 20.00% | 77.78% | - | 53.85% | - | 54.55% | - | 46.67% | 55.56% | 31.25% | - | 166.67% | -112.50% | -83.33% | - | -39.29% | 10.00% | -12.90% | - | -80.95% | -50.00% | 9.09% | 323.08% | 333.33% | 18.18% | 28.57% |
| Timing | - | Pre-market | Pre-market | - | Pre-market | Pre-market | Pre-market | - | Pre-market | - | Pre-market | - | Pre-market | Pre-market | Pre-market | - | After-hours | Pre-market | Pre-market | - | Pre-market | Pre-market | Pre-market | - | Pre-market | Pre-market | Pre-market | After-hours | After-hours | After-hours | Pre-market |
Key Statistics & Ratios
- Market Cap
- $2.35B
- Enterprise Value
- $2.65B
- Trailing P/E
- 0.00
- Forward P/E
- 22.88
- Price / Sales
- 2.06
- Price / Book
- 3.13
- EPS
- $-2.44
- Book Value
- $6.07
- Revenue (TTM)
- $1.14B
- Gross Profit (TTM)
- $677.39M
- EBITDA
- $301.02M
- Profit Margin
- -41.55%
- Operating Margin
- 12.84%
- Return on Equity
- -47.65%
- Return on Assets
- 3.28%
- Shares Outstanding
- 170.16M
- Shares Float
- 167.89M
- Beta
- 1.76
- Dividend Yield
- 0.00%
- Dividend Rate
- $0
- Payout Ratio
- 0.00%
Ownership Breakdown
- Institutions
- 21.40%
- Insiders
- 1.34%
- Retail / Other
- 77.26%
Top Institutional Holders
- AdvisorShares Investments, LLC10.64M5.53%
- Oakmont Corp1.51M0.78%
- NANO CAP NEW MILLENNIUM GROWTH FUND L P145.00K0.08%
- Bluechip Wealth Advisors LLC114.46K0.06%
- JW Asset Management, LLC83.87K0.04%
- Harbor Advisors LLC42.64K0.02%
- Albert D Mason Inc39.20K0.02%
- Zurcher Kantonalbank38.80K0.02%
Top Fund Holders
- AdvisorShares Pure US Cannabis ETF9.62M5.00%
- Amplify Seymour Cannabis ETF1.00M0.52%
- AdvisorShares Pure Cannabis ETF496.91K0.26%
- Human Intelligence R427.00K0.22%
- IA Canadian Equity Growth356.41K0.19%
- Purpose Global Resource Series A342.56K0.18%
- iA Cdn Eq Sm Cap (iA) SRP7575P500F305.36K0.16%
- CANSOUL Fonds Hanf Aktien Global EUR C82.00K0.04%
- Northern Small Cap Value55.31K0.03%
- Cannabis Opportunity Fund A41.37K0.02%
- IA Clarington Canadian Leaders Cl Sr F38.95K0.02%
- iA North Ame Eq Ecoflex&MyEd32.69K0.02%